Home › Trials › NCT02832245

Registry for patients with venous blood clots

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Observational Foundation for the study of VTE diseases. (FUENTE) · NCT02832245

This study is creating a database of patients with blood clots to help doctors better understand how to treat them and identify those at higher risk for complications.

Quick facts

Study typeObservational
Enrollment120000 (estimated)
SexAll
SponsorFoundation for the study of VTE diseases. (FUENTE) Academic / other
Locations257 sites (New Haven, Connecticut and 256 other locations)
Trial IDNCT02832245 on ClinicalTrials.gov

What this trial studies

The Computerized Registry of Patients with Venous Thromboembolism (RIETE) aims to create a comprehensive database of patients diagnosed with venous thromboembolism (VTE). This observational project collects data on various patient subgroups often excluded from clinical trials, such as pregnant women and those with severe comorbidities. By analyzing this data, the registry seeks to enhance physician understanding of VTE management and develop predictive scores for identifying high-risk patients. The goal is to reduce mortality and complications associated with thromboembolic events.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals diagnosed with confirmed venous thromboembolism.

Not a fit: Patients currently participating in a therapeutic clinical trial with an unknown drug may not benefit from this study.

Why it matters

Potential benefit: If successful, this registry could significantly improve the management and outcomes of patients with venous thromboembolism.

How similar studies have performed: Other studies utilizing registry approaches have shown success in improving patient outcomes, indicating that this methodology is promising.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Confirmed VTE (acute deep-vein thrombosis, pulmonary embolism and/or superficial venous thrombosis) by objective tests.
* Informed consent to the participation in the study, according to the requirements of the ethics committee within each hospital.

Exclusion Criteria:

* Participation in a therapeutic clinical trial with an unknown drug.
* Inability to the 3 month follow-up

Where this trial is running

New Haven, Connecticut and 256 other locations

+207 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Venous Thromboembolism
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.